Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0081 Transporter Info
Gene Name	SLC11A2
Transporter Name	Natural resistance-associated macrophage protein 2
Gene ID	4891
UniProt ID	P49281

Post-Translational Modification of This DT
Overview of SLC11A2 Modification Sites with Functional and Structural Information
Sequence	M V L G P E Q K M S D D S V S G D H G E S A S L G N I N P A Y S N P S L S Q S P G D S E E Y F A T Y F N E K I S I P E E E Y S C F S F R K L W A F T G P G F L M S I A Y L D P G N I E S D L Q S G A V A G F K L L W I L L L A T L V G L L L Q R L A A R L G V V T G L H L A E V C H R Q Y P K V P R V I L W L M V E L A I I G S D M Q E V I G S A I A I N L L S V G R I P L W G G V L I T I A D T F V F L F L D K Y G L R K L E A F F G F L I T I M A L T F G Y E Y V T V K P S Q S Q V L K G M F V P S C S G C R T P Q I E Q A V G I V G A V I M P H N M Y L H S A L V K S R Q V N R N N K Q E V R E A N K Y F F I E S C I A L F V S F I I N V F V V S V F A E A F F G K T N E Q V V E V C T N T S S P H A G L F P K D N S T L A V D I Y K G G V V L G C Y F G P A A L Y I W A V G I L A A G Q S S T M T G T Y S G Q F V M E G F L N L K W S R F A R V V L T R S I A I I P T L L V A V F Q D V E H L T G M N D F L N V L Q S L Q L P F A L I P I L T F T S L R P V M S D F A N G L G W R I A G G I L V L I I C S I N M Y F V V V Y V R D L G H V A L Y V V A A V V S V A Y L G F V F Y L G W Q C L I A L G M S F L D C G H T C H L G L T A Q P E L Y L L N T M D A D S L V S R
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC11A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	336
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC11A2 Asparagine 336 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC11A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	349
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC11A2 Asparagine 349 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Affecting the polarized distribution of the SLC11A2 at the apical plasma membrane			[2]
Role of PTM	Surface Expression Modulation
Studied Phenotype	Larynx cancer [ICD11:2C23.1-2C23.5]
Experimental Material(s)	Human larynx carcinoma (HEp-2) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-glycosylation at SLC11A2 have been reported to affect its polarized distribution at the apical plasma membrane.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC11A2			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	137
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC11A2 Cystine 137 has the potential to affect its expression or activity.
Phosphorylation
Serine	15 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC11A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 10 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	13
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 13 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	15
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 15 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	21
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 21 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 23 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC11A2			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 32 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	35
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 35 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	37
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 37 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	39
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 39 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	43
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 43 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC11A2			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	56
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 56 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC11A2			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	66
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 66 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC11A2			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	81
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 81 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC11A2			[4] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	564
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 564 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC11A2			[4] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	567
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Serine 567 has the potential to affect its expression or activity.
Tyrosine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	31
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Tyrosine 31 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC11A2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	46
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Tyrosine 46 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC11A2			[11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC11A2 Tyrosine 84 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC11A2			[13]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	245
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC11A2 Cystine 245 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC11A2			[14]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	64
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC11A2 Cystine 64 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: NRAM2_HUMAN)
2	Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. Mol Biol Cell. 2002 Dec;13(12):4371-87.
3	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
4	An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
5	Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation. Sci Signal. 2015 Apr 28;8(374):ra40.
6	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
7	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
8	Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 2018 Jul;20(7):668-677.
9	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
10	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
11	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
12	Identification of phosphopeptides with unknown cleavage specificity by a de novo sequencing assisted database search strategy. Proteomics. 2014 Nov;14(21-22):2410-6.
13	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
14	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence